Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

October UNC Health System Pharmacy Resident CE Series (Home Studies)


CE Hours

3.50

CE Units

0.350

Activity Type

  • Knowledge

Accreditation(s)

Participants have 60 days from the start of their program to claim CE credit and verify it has been upload to CPE Monitor. If your program requires the completion of a post test/eval/survey those items MUST be done before that 60 day window closes to receive credit for that program. Statements of credit can be viewed and printed from CPE Monitor. Statements of credit will no longer be printed and mailed to the participant. **No partial individual session credit will be given**
 
PAYMENT NOTE: During the registration process, if a fee is required, please enter the zip code associated with your credit card's BILLING ADDRESS. For security purposes payments are processed through a separate system, so when prompted, please click “ok” to be taken to that site and complete your registration. Upon successful registration of this program you will receive an email confirmation/receipt and will be returned to this program page. When you are retuned to this page you will see a note at the top of the page reading “You are registered for this program.”
If you are not automatically returned to this page or see only a blank white screen your transaction was not successful, and you will need to try again.

 

If paying by check please mail to the address below:

UNC Eshelman School of Pharmacy
Attn: Continuing Education
301 Pharmacy Lane, CB# 7574 Beard Hall
Chapel Hill, NC 27599
 
 
Accreditation Council for Pharmacy Education
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To receive CE credit, participants must complete the CE attendance form and the online evaluation of the program (instructions to be emailed). Statements of credit can be viewed and printed in CPE Monitor approximately 2 to 3 weeks after the program and you have completed any needed requirements. **No partial credit will be available**

Co-Sponsor(s)

UNC Health System

Support/Credits

 
Cancelations: Cancelations must be received in writing/email to the Office of Continuing Education at least 48 hours prior to start date to receive a full refund. No refunds will be given within 48 hours of the start date.
 
 
IMPORTANT: UNC HEALTH SYSTEM EMPLOYEES AND UNC ESHELMAN SCHOOL OF PHARMACY STUDENTS ONLY
 
UNC Health System Employees and ESOP Students are able to attend this Resident Series at no charge to them. If you are a Health System Employee or Student please follow the steps below. This only applies to this series. Other UNC ESOP CE programs are available to register at the fee listed on that page.
  1. UNC Health System Employees and UNC ESOP Students should register using your UNC email address. UNC Employees - please select your employment location during the registration process. UNC Students - please respond "Yes" to the "Are you a UNC Student" question.
  2. Select the “Check” payment method on the registration page. Your employment will be verified prior to credit being uploaded
Program Materials: A link to the program recording and presentation slides will be found under the session by expanding the module after completing registration. Once the content has been completed return to this page to complete the post assessment and evaluation. After those have been submitted your credit will automattically be uploaded to CPE Monitor.

 

 

   

This presentation will help increase and enhance our understanding of how to treat patients with Charcot-Marie Tooth disease who also need concomitant vincristine in their ALL therapy.
 

Objectives

  • Discuss Charcot-Marie Tooth Disease (CMT)
  • Examine the implications of CMT Disease on patients with pediatric acute lymphoblastic leukemia (ALL)
  • Analyze management options for ALL in patients with CMT disease

Speaker(s)/Author(s)

Jordan Wallace, PharmD
PGY2 Pediatric Hematology/Oncology Pharmacy Resident

Activity Number

0046-9999-21-242-H01-P

Release Date: Oct 7, 2021
Credit Expiration Date: Oct 7, 2022

CE Hours

0.50

Fee

$5.00
   

   

Objectives

  • Recall the World Health Organization's definition for group 3 pulmonary hypertension
  • Describe at least 2 proposed mechanisms for the development of pulmonary hypertension in interstitial lung disease
  • Assess the evidence for the use of antifibrotic agents in PH-ILD
  • Discuss the risk and benefits of vasodilators in PH-ILD

Speaker(s)/Author(s)

Savannah Jones, PharmD

Activity Number

0046-9999-21-251-H01-P

Release Date: Oct 14, 2021
Credit Expiration Date: Oct 14, 2022

CE Hours

1.00

Fee

$10.00
   

   

This session will provide up-to-date knowledge and provide evaluation of current literature in order to inform and advise therapy considerations and concerns surrounding best practices of prevention of CMV infection for solid organ transplant patients.
 
 
Presentation Slides available for download at the bottom of this module. You MUST be signed into your registered account to access this content

Objectives

  • Review current guidelines for the prevention of CMV in solid organ transplant patients.
  • Compare and contrast the benefits and pitfalls of using letermovir for preventing CMV in solid organ transplant patients.
  • Discuss the utility of T-cell assays in the management of CMV in the transplant population.
  • Construct an algorithm for therapy considerations in the prevention of CMV for solid organ transplant patients

Speaker(s)/Author(s)

Alyson Prom, PharmD
PGY1 Pharmacy Resident

Activity Number

0046-9999-21-238-H01-P

Release Date: Oct 21, 2021
Credit Expiration Date: Oct 21, 2022

CE Hours

1.00

Fee

$10.00
   

   

This presentation will help pharmacists understand the key differences between Tenecteplase and Alteplase. Recent literature has been published supporting the use of tenecteplase in patients with acute ischemic stroke highlighting the benefits of cost savings, ease of administration, and similar effiacy and safety to Alteplase. This presentation will help pharmacists to devise a strategy for selecting Alteplase or Tenecteplase in acute ischemic stroke.

Objectives

  • Outline key differences between Tenecteplase and Alteplase
  • Summarize current literature for the use of Tenecteplase in patients with acute ischemic stroke
  • Discuss a strategy for selecting Alteplase or Tenecteplase in Acute Ischemic Stroke

Speaker(s)/Author(s)

Whitney Ly, PharmD
PGY-1 Acute Care Pharmacy Resident

Activity Number

0046-9999-21-258-H01-P

Release Date: Oct 28, 2021
Credit Expiration Date: Oct 28, 2022

CE Hours

1.00

Fee

$10.00